Highlights of weekly biotech stock moves

ALK-Abello A/S (CSE:ALK-B) added DKK24 to DKK616 on Christmas week after FDA said its Allergenic Products Advisory Committee will meet on Jan. 28 to discuss a BLA for Ragwitek ragweed Allergy Immunotherapy Tablet (AIT) to treat ragweed pollen-induced allergic rhinitis, with or without conjunctivitis.

The pharma submitted the BLA in March and said it expects a decision in 1H14. Merck & Co. Inc. (NYSE:MRK) has exclusive North American rights...